Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Buckingham

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systemsTandy Aye, Jen Block, Bruce Buckingham
Diabetes Technology & Therapeutics|February 14, 2015
Diabetes technology and the human factorAlon Liberman, Moshe Phillip, Bruce Buckingham
Diabetes Technology & Therapeutics|February 1, 2014
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Real-time continuous glucose monitoringBruce Buckingham, Kimberly Caswell, Darrell M Wilson
The New England Journal of Medicine|March 6, 2024
Digital Technology for Diabetes. ReplyMichael S Hughes, Ananta Addala, Bruce Buckingham
The New England Journal of Medicine|December 4, 2023
Digital Technology for DiabetesMichael S Hughes, Ananta Addala, Bruce Buckingham
Diabetes Technology & Therapeutics|June 20, 2018
Advances in Care for Insulin-Requiring Patients Without Closed LoopRayhan A Lal, Bruce Buckingham, David M Maahs
The Journal of Pediatrics|November 9, 2015
Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial PancreasGregory P Forlenza, Bruce Buckingham, David M Maahs
Pediatric Diabetes|June 11, 2004
Initiation of insulin glargine in children and adolescents with type 1 diabetesChin Yao Tan, Darrell M Wilson, Bruce Buckingham
Pediatric Diabetes|May 13, 2022
Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetesBruce Buckingham, Jennifer Sherr, Steven J Prestrelski, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systemsTandy Aye, Jen Block, Bruce Buckingham
Diabetes Technology & Therapeutics|February 14, 2015
Diabetes technology and the human factorAlon Liberman, Moshe Phillip, Bruce Buckingham
Diabetes Technology & Therapeutics|February 1, 2014
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Real-time continuous glucose monitoringBruce Buckingham, Kimberly Caswell, Darrell M Wilson
The New England Journal of Medicine|March 6, 2024
Digital Technology for Diabetes. ReplyMichael S Hughes, Ananta Addala, Bruce Buckingham
The New England Journal of Medicine|December 4, 2023
Digital Technology for DiabetesMichael S Hughes, Ananta Addala, Bruce Buckingham
Diabetes Technology & Therapeutics|June 20, 2018
Advances in Care for Insulin-Requiring Patients Without Closed LoopRayhan A Lal, Bruce Buckingham, David M Maahs
The Journal of Pediatrics|November 9, 2015
Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial PancreasGregory P Forlenza, Bruce Buckingham, David M Maahs
Pediatric Diabetes|June 11, 2004
Initiation of insulin glargine in children and adolescents with type 1 diabetesChin Yao Tan, Darrell M Wilson, Bruce Buckingham
Pediatric Diabetes|May 13, 2022
Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetesBruce Buckingham, Jennifer Sherr, Steven J Prestrelski, et al.
Pageof 11